Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers.
Johnson
S
S
Department of Medicine, Northwestern University Medical School and the Veterans Affairs Chicago Healthcare System, Lakeside Division, Chicago, IL, USA.
Baraboutis
J G
JG
D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003875:Drug Eruptions / Q000209:etiology*; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional / Q000517:prevention & control; D016602:Needlestick Injuries; D019829:Nevirapine / Q000009:adverse effects* / Q000627:therapeutic use; D016273:Occupational Exposure; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine